Application 021164

Type
NDA
Sponsor
FABRE KRAMER

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EXXUAGEPIRONE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 18.2MG BASEYesYes
002EXXUAGEPIRONE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 36.3MG BASEYesNo
003EXXUAGEPIRONE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 54.5MG BASE YesNo
004EXXUAGEPIRONE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 72.6MG BASEYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82531SUPPL 2025-06-10
82501SUPPL 2025-06-09
76672ORIG 2023-11-28
75557ORIG 2023-09-25
75552ORIG 2023-09-25